Dwayne C. Jones

Array ( [id] => 4418584 [patent_doc_number] => 06194404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Process for the isolation of galanthamine' [patent_app_type] => 1 [patent_app_number] => 9/130883 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1860 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194404.pdf [firstpage_image] =>[orig_patent_app_number] => 130883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249018 [patent_doc_number] => 06136863 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Antifungal agents' [patent_app_type] => 1 [patent_app_number] => 9/131281 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3805 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136863.pdf [firstpage_image] =>[orig_patent_app_number] => 131281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4155989 [patent_doc_number] => 06107328 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Use of 5HT.sub.1B receptor antagonist for the treatment of vascular disease' [patent_app_type] => 1 [patent_app_number] => 9/043346 [patent_app_country] => US [patent_app_date] => 1998-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4319 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107328.pdf [firstpage_image] =>[orig_patent_app_number] => 043346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099155 [patent_doc_number] => 06048855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Topical composition containing capsazepine' [patent_app_type] => 1 [patent_app_number] => 9/068237 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3567 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048855.pdf [firstpage_image] =>[orig_patent_app_number] => 068237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119581 [patent_doc_number] => 06071968 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant' [patent_app_type] => 1 [patent_app_number] => 9/097414 [patent_app_country] => US [patent_app_date] => 1998-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 7149 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071968.pdf [firstpage_image] =>[orig_patent_app_number] => 097414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4208516 [patent_doc_number] => 06028094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Agent for prevention and suppression of dry coughing caused by angiotensin converting enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/077805 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2835 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028094.pdf [firstpage_image] =>[orig_patent_app_number] => 077805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183478 [patent_doc_number] => 06020375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Bactericidal composition' [patent_app_type] => 1 [patent_app_number] => 9/094479 [patent_app_country] => US [patent_app_date] => 1998-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1540 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020375.pdf [firstpage_image] =>[orig_patent_app_number] => 094479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408545 [patent_doc_number] => 06239102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 9/091072 [patent_app_country] => US [patent_app_date] => 1998-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7456 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239102.pdf [firstpage_image] =>[orig_patent_app_number] => 091072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132899 [patent_doc_number] => 06147070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Methods and compositions for controlling iron stores to treat and cure disease states' [patent_app_type] => 1 [patent_app_number] => 9/092521 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6404 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147070.pdf [firstpage_image] =>[orig_patent_app_number] => 092521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023240 [patent_doc_number] => 05993786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Anti-carious chewing gums, candies, gels, toothpastes and dentifrices' [patent_app_type] => 1 [patent_app_number] => 9/088869 [patent_app_country] => US [patent_app_date] => 1998-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7916 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993786.pdf [firstpage_image] =>[orig_patent_app_number] => 088869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037670 [patent_doc_number] => 06872819 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-29 [patent_title] => 'Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells' [patent_app_type] => utility [patent_app_number] => 09/700142 [patent_app_country] => US [patent_app_date] => 1998-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6238 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872819.pdf [firstpage_image] =>[orig_patent_app_number] => 09700142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353636 [patent_doc_number] => 06291509 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Synergistic immunosuppressant composition containing a 2,2\'-bi-1H-pyrrole compound' [patent_app_type] => 1 [patent_app_number] => 9/068555 [patent_app_country] => US [patent_app_date] => 1998-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5144 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291509.pdf [firstpage_image] =>[orig_patent_app_number] => 068555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459413 [patent_doc_number] => 06426415 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-30 [patent_title] => 'Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity' [patent_app_type] => B1 [patent_app_number] => 09/079508 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15100 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426415.pdf [firstpage_image] =>[orig_patent_app_number] => 09079508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359080 [patent_doc_number] => 06174899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Orally administered analgesic composition comprising myfadol' [patent_app_type] => 1 [patent_app_number] => 9/079015 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2392 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174899.pdf [firstpage_image] =>[orig_patent_app_number] => 079015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108483 [patent_doc_number] => 06022901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Administration of resveratrol to prevent or treat restenosis following coronary intervention' [patent_app_type] => 1 [patent_app_number] => 9/078300 [patent_app_country] => US [patent_app_date] => 1998-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8974 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022901.pdf [firstpage_image] =>[orig_patent_app_number] => 078300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4368918 [patent_doc_number] => 06274624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Antiproliferative and neurotrophic molecules' [patent_app_type] => 1 [patent_app_number] => 9/075887 [patent_app_country] => US [patent_app_date] => 1998-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 12212 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274624.pdf [firstpage_image] =>[orig_patent_app_number] => 075887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032605 [patent_doc_number] => 05994393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Alpha-lipoic acid with novel modification' [patent_app_type] => 1 [patent_app_number] => 9/074645 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1865 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994393.pdf [firstpage_image] =>[orig_patent_app_number] => 074645 [rel_patent_id] =>[rel_patent_doc_number] =>)